Levacetylleucine

Moderate

Levacetylleucine Relugolix Orgovyx Explained Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Levacetylleucine Colchicine Colcrys Explained Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Levacetylleucine Aliskiren Tekturna Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Levacetylleucine Apixaban Eliquis Explained Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Levacetylleucine Betrixaban Bevyxxa® Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Levacetylleucine Afatinib Gilotrif Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Levacetylleucine Cyclosporine Injection Atopica Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Levacetylleucine Cyclosporine Ophthalmic Cequa Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Levacetylleucine Dabigatran Pradaxa® Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Levacetylleucine Dabigatran Etexilate Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Levacetylleucine Darolutamide Nubeqa Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Levacetylleucine Digoxin Cardoxin® Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Levacetylleucine Doxorubicin Adriamycin Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Levacetylleucine Edoxaban Savaysa Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Levacetylleucine Everolimus Afinitor Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Levacetylleucine Fexofenadine Allegra Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Levacetylleucine Futibatinib Lytgobi Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Levacetylleucine Gilteritinib Xospata Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Levacetylleucine Linagliptin Tradjenta Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Levacetylleucine Loperamide Diamode Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Levacetylleucine Maraviroc Selzentry Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Levacetylleucine Naldemedine Symproic Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details Levacetylleucine Nintedanib Ofev Increased P-gp inhibitor exposure and an increased risk of P-gp substrate-related adverse reactions Details